What Is TECH Fair Value?
Bio-Techne (TECH) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, Bio-Techne (TECH) has a composite fair value estimate of $21.79 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $72.35, suggesting the stock is overvalued by 69.9%.
Data as of August 29, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$21.79
vs. current price of $72.35(-69.9%)
How Is TECH Fair Value Calculated?
Four independent models estimate what TECH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
TECH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$23.72
-67.2%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$5.01
-93.1%Overvalued
Inputs used
TECH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$24.72
-65.8%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$20.38
-71.8%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $72.35 is 67.2% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $251.8M | $226.2M |
| Year 2 | $276.1M | $222.7M |
| Year 3 | $302.7M | $219.4M |
| Year 4 | $331.9M | $216.0M |
| Year 5 | $363.9M | $212.7M |
| Year 6 | $399.0M | $209.5M |
| Year 7 | $437.5M | $206.3M |
| Year 8 | $479.7M | $203.2M |
| Year 9 | $526.0M | $200.1M |
| Year 10 | $576.7M | $197.1M |
| Terminal Value | $6.69B | $2.29B |
What Are TECH's Key Financial Metrics?
Earnings & Growth
Current Price
$72.35
EPS (TTM)
$1.16
Forward P/E
31.2
Profit Margin
15.0%
Cash & Balance Sheet
Free Cash Flow
229.7M
EBITDA
334.1M
Book Value
$13.32
Total Debt
289.1M
What Do Analysts Say About TECH?
Low
$50.00
Average
$70.73
High
$73.00
Upside
-2.2%
TECH Fair Value FAQ
What is the fair value of TECH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), TECH's estimated fair value is $21.79. The stock is currently trading at $72.35, which makes it overvalued by our analysis.
How is TECH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is TECH overvalued or undervalued?
Based on our analysis, TECH is overvalued. The current price of $72.35 is 69.9% above our estimated fair value of $21.79.
What do Wall Street analysts say about TECH?
11 analysts cover Bio-Techne with a consensus rating of "Hold." The average price target is $70.73, ranging from $50.00 to $73.00. This implies 2.2% downside from the current price.